机构投资者增加对Gilead Science的投资,增强市场信心。 Institutional investors increase investment in Gilead Sciences, boosting market confidence.

Gilead Science, Inc.看到各种机构投资者增加了投资,表明对生物制药公司的信心。 Gilead Sciences, Inc. has seen increased investment from various institutional investors, signaling confidence in the biopharmaceutical firm. 股票的营业额为83.05美元,市场上限为1 034.47亿美元。 The stock opened at $83.05, with a market cap of $103.47 billion. 吉利德在上个季度的每股收益为2.01美元,超过预期,并宣布每季度的股息为0.77美元. For the last quarter, Gilead reported earnings per share of $2.01, exceeding expectations, and announced a quarterly dividend of $0.77. 分析员提高了评级,价格目标达到93美元。 Analysts have upgraded their ratings, with price targets reaching up to $93.00.